IBDEI1JB ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,24839,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24839,1,3,0)
;;=3^Resp Failure,Chronic,Unspec w/ Hypoxia or Hypercapnia
;;^UTILITY(U,$J,358.3,24839,1,4,0)
;;=4^J96.10
;;^UTILITY(U,$J,358.3,24839,2)
;;=^5008350
;;^UTILITY(U,$J,358.3,24840,0)
;;=J96.12^^85^1092^10
;;^UTILITY(U,$J,358.3,24840,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24840,1,3,0)
;;=3^Resp Failure,Chronic w/ Hypercapnia
;;^UTILITY(U,$J,358.3,24840,1,4,0)
;;=4^J96.12
;;^UTILITY(U,$J,358.3,24840,2)
;;=^5008352
;;^UTILITY(U,$J,358.3,24841,0)
;;=J96.11^^85^1092^11
;;^UTILITY(U,$J,358.3,24841,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24841,1,3,0)
;;=3^Resp Failure,Chronic w/ Hypoxia
;;^UTILITY(U,$J,358.3,24841,1,4,0)
;;=4^J96.11
;;^UTILITY(U,$J,358.3,24841,2)
;;=^5008351
;;^UTILITY(U,$J,358.3,24842,0)
;;=R06.03^^85^1092^4
;;^UTILITY(U,$J,358.3,24842,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24842,1,3,0)
;;=3^Resp Distress,Acute
;;^UTILITY(U,$J,358.3,24842,1,4,0)
;;=4^R06.03
;;^UTILITY(U,$J,358.3,24842,2)
;;=^5151591
;;^UTILITY(U,$J,358.3,24843,0)
;;=J80.^^85^1092^3
;;^UTILITY(U,$J,358.3,24843,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24843,1,3,0)
;;=3^Resp Distress Syndrome,Acute (ARDS)
;;^UTILITY(U,$J,358.3,24843,1,4,0)
;;=4^J80.
;;^UTILITY(U,$J,358.3,24843,2)
;;=^5008294
;;^UTILITY(U,$J,358.3,24844,0)
;;=S23.9XXA^^85^1093^20
;;^UTILITY(U,$J,358.3,24844,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24844,1,3,0)
;;=3^Sprain Thorax,Unspec Part,Initial Encounter
;;^UTILITY(U,$J,358.3,24844,1,4,0)
;;=4^S23.9XXA
;;^UTILITY(U,$J,358.3,24844,2)
;;=^5023267
;;^UTILITY(U,$J,358.3,24845,0)
;;=I69.928^^85^1093^14
;;^UTILITY(U,$J,358.3,24845,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24845,1,3,0)
;;=3^Speech/Lang Deficits Following Unspec Cerebrovascular Disease
;;^UTILITY(U,$J,358.3,24845,1,4,0)
;;=4^I69.928
;;^UTILITY(U,$J,358.3,24845,2)
;;=^5007557
;;^UTILITY(U,$J,358.3,24846,0)
;;=S13.4XXA^^85^1093^19
;;^UTILITY(U,$J,358.3,24846,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24846,1,3,0)
;;=3^Sprain Ligaments Cervical Spine,Initial Encounter
;;^UTILITY(U,$J,358.3,24846,1,4,0)
;;=4^S13.4XXA
;;^UTILITY(U,$J,358.3,24846,2)
;;=^5022028
;;^UTILITY(U,$J,358.3,24847,0)
;;=M15.3^^85^1093^5
;;^UTILITY(U,$J,358.3,24847,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24847,1,3,0)
;;=3^Secondary Multiple Arthritis
;;^UTILITY(U,$J,358.3,24847,1,4,0)
;;=4^M15.3
;;^UTILITY(U,$J,358.3,24847,2)
;;=^5010765
;;^UTILITY(U,$J,358.3,24848,0)
;;=L08.9^^85^1093^10
;;^UTILITY(U,$J,358.3,24848,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24848,1,3,0)
;;=3^Skin Infection,Unspec
;;^UTILITY(U,$J,358.3,24848,1,4,0)
;;=4^L08.9
;;^UTILITY(U,$J,358.3,24848,2)
;;=^5009082
;;^UTILITY(U,$J,358.3,24849,0)
;;=L98.9^^85^1093^11
;;^UTILITY(U,$J,358.3,24849,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24849,1,3,0)
;;=3^Skin/Subcutaneous Tissue Disorder,Unspec
;;^UTILITY(U,$J,358.3,24849,1,4,0)
;;=4^L98.9
;;^UTILITY(U,$J,358.3,24849,2)
;;=^5009595
;;^UTILITY(U,$J,358.3,24850,0)
;;=R22.2^^85^1093^21
;;^UTILITY(U,$J,358.3,24850,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,24850,1,3,0)
;;=3^Swelling,Mass & Lump,Trunk
;;^UTILITY(U,$J,358.3,24850,1,4,0)
;;=4^R22.2
;;^UTILITY(U,$J,358.3,24850,2)
;;=^5019286
;;^UTILITY(U,$J,358.3,24851,0)
;;=M54.31^^85^1093^3
;;^UTILITY(U,$J,358.3,24851,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1JB 3793 printed Sep 23, 2025@19:45:50 Page 2
IBDEI1JB ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,24839,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,24839,1,3,0)
+4 ;;=3^Resp Failure,Chronic,Unspec w/ Hypoxia or Hypercapnia
+5 ;;^UTILITY(U,$J,358.3,24839,1,4,0)
+6 ;;=4^J96.10
+7 ;;^UTILITY(U,$J,358.3,24839,2)
+8 ;;=^5008350
+9 ;;^UTILITY(U,$J,358.3,24840,0)
+10 ;;=J96.12^^85^1092^10
+11 ;;^UTILITY(U,$J,358.3,24840,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,24840,1,3,0)
+14 ;;=3^Resp Failure,Chronic w/ Hypercapnia
+15 ;;^UTILITY(U,$J,358.3,24840,1,4,0)
+16 ;;=4^J96.12
+17 ;;^UTILITY(U,$J,358.3,24840,2)
+18 ;;=^5008352
+19 ;;^UTILITY(U,$J,358.3,24841,0)
+20 ;;=J96.11^^85^1092^11
+21 ;;^UTILITY(U,$J,358.3,24841,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,24841,1,3,0)
+24 ;;=3^Resp Failure,Chronic w/ Hypoxia
+25 ;;^UTILITY(U,$J,358.3,24841,1,4,0)
+26 ;;=4^J96.11
+27 ;;^UTILITY(U,$J,358.3,24841,2)
+28 ;;=^5008351
+29 ;;^UTILITY(U,$J,358.3,24842,0)
+30 ;;=R06.03^^85^1092^4
+31 ;;^UTILITY(U,$J,358.3,24842,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,24842,1,3,0)
+34 ;;=3^Resp Distress,Acute
+35 ;;^UTILITY(U,$J,358.3,24842,1,4,0)
+36 ;;=4^R06.03
+37 ;;^UTILITY(U,$J,358.3,24842,2)
+38 ;;=^5151591
+39 ;;^UTILITY(U,$J,358.3,24843,0)
+40 ;;=J80.^^85^1092^3
+41 ;;^UTILITY(U,$J,358.3,24843,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,24843,1,3,0)
+44 ;;=3^Resp Distress Syndrome,Acute (ARDS)
+45 ;;^UTILITY(U,$J,358.3,24843,1,4,0)
+46 ;;=4^J80.
+47 ;;^UTILITY(U,$J,358.3,24843,2)
+48 ;;=^5008294
+49 ;;^UTILITY(U,$J,358.3,24844,0)
+50 ;;=S23.9XXA^^85^1093^20
+51 ;;^UTILITY(U,$J,358.3,24844,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,24844,1,3,0)
+54 ;;=3^Sprain Thorax,Unspec Part,Initial Encounter
+55 ;;^UTILITY(U,$J,358.3,24844,1,4,0)
+56 ;;=4^S23.9XXA
+57 ;;^UTILITY(U,$J,358.3,24844,2)
+58 ;;=^5023267
+59 ;;^UTILITY(U,$J,358.3,24845,0)
+60 ;;=I69.928^^85^1093^14
+61 ;;^UTILITY(U,$J,358.3,24845,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,24845,1,3,0)
+64 ;;=3^Speech/Lang Deficits Following Unspec Cerebrovascular Disease
+65 ;;^UTILITY(U,$J,358.3,24845,1,4,0)
+66 ;;=4^I69.928
+67 ;;^UTILITY(U,$J,358.3,24845,2)
+68 ;;=^5007557
+69 ;;^UTILITY(U,$J,358.3,24846,0)
+70 ;;=S13.4XXA^^85^1093^19
+71 ;;^UTILITY(U,$J,358.3,24846,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,24846,1,3,0)
+74 ;;=3^Sprain Ligaments Cervical Spine,Initial Encounter
+75 ;;^UTILITY(U,$J,358.3,24846,1,4,0)
+76 ;;=4^S13.4XXA
+77 ;;^UTILITY(U,$J,358.3,24846,2)
+78 ;;=^5022028
+79 ;;^UTILITY(U,$J,358.3,24847,0)
+80 ;;=M15.3^^85^1093^5
+81 ;;^UTILITY(U,$J,358.3,24847,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,24847,1,3,0)
+84 ;;=3^Secondary Multiple Arthritis
+85 ;;^UTILITY(U,$J,358.3,24847,1,4,0)
+86 ;;=4^M15.3
+87 ;;^UTILITY(U,$J,358.3,24847,2)
+88 ;;=^5010765
+89 ;;^UTILITY(U,$J,358.3,24848,0)
+90 ;;=L08.9^^85^1093^10
+91 ;;^UTILITY(U,$J,358.3,24848,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,24848,1,3,0)
+94 ;;=3^Skin Infection,Unspec
+95 ;;^UTILITY(U,$J,358.3,24848,1,4,0)
+96 ;;=4^L08.9
+97 ;;^UTILITY(U,$J,358.3,24848,2)
+98 ;;=^5009082
+99 ;;^UTILITY(U,$J,358.3,24849,0)
+100 ;;=L98.9^^85^1093^11
+101 ;;^UTILITY(U,$J,358.3,24849,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,24849,1,3,0)
+104 ;;=3^Skin/Subcutaneous Tissue Disorder,Unspec
+105 ;;^UTILITY(U,$J,358.3,24849,1,4,0)
+106 ;;=4^L98.9
+107 ;;^UTILITY(U,$J,358.3,24849,2)
+108 ;;=^5009595
+109 ;;^UTILITY(U,$J,358.3,24850,0)
+110 ;;=R22.2^^85^1093^21
+111 ;;^UTILITY(U,$J,358.3,24850,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,24850,1,3,0)
+114 ;;=3^Swelling,Mass & Lump,Trunk
+115 ;;^UTILITY(U,$J,358.3,24850,1,4,0)
+116 ;;=4^R22.2
+117 ;;^UTILITY(U,$J,358.3,24850,2)
+118 ;;=^5019286
+119 ;;^UTILITY(U,$J,358.3,24851,0)
+120 ;;=M54.31^^85^1093^3
+121 ;;^UTILITY(U,$J,358.3,24851,1,0)
+122 ;;=^358.31IA^4^2
